Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

Patent 11945785 was granted and assigned to Biomea Fusion, Inc. on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Biomea Fusion, Inc.

0

Current Assignee

Biomea Fusion, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yongli Su0

Thu Phan0

Neil Howard Squires0

Ravindra B. Upasani0

Solomon B. Ungashe0

Xiaodong Wang0

Amna Trinity-Turjuman Adam0

David Sperandio0

...

Date of Patent

April 2, 2024

0

Patent Application Number

181483110

Date Filed

December 29, 2022

0

Patent Citations

US Patent 8969336 Diamino heterocyclic carboxamide compound

0

US Patent 9051310 Nicotinamide derivative or salt thereof

0

US Patent 9085540 Pyrazinecarboxamide compound

0

US Patent 9145415 Nitrogen-containing heterocyclic compound or salt thereof

0

US Patent 9340492 Meta-Diarylaniline or meta-diarylpyridinamine compound, preparation method and medical uses thereof

0

US Patent 9487491 Diamino heterocyclic carboxamide compound

0

US Patent 9650516 Acid dyes, process for the production thereof and their use

0

US Patent 7083668 Ink set, ink cartridge, ink jet printer and recording method

0

...

Patent Primary Examiner

Jeffrey H Murray

0

CPC Code

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool